ACS: COVID-19 Emergency General Surgery Guidelines
- Laila Zomorodian, MD
- Mar 25, 2020
- 1 min read
Online March 24, 2020
Acute Hemorrhoidal Thrombosis/Necrosis If >48 hrs and pain is controlled, defer operation.
If localized, excision under local anesthesia in outpatient setting.
If extensive, excise in OR under regional or general anesthesia.
Perirectal Abscess Use systemic antibiotics as indicated.
If superficial and localized, incision and drainage with local anesthesia.
If large and/or deeply located abscesses consider interventional radiology
Incision and drainage in OR as indicated.
Acute Pancreatitis with Necrosis Supportive care and resuscitation. Antimicrobial therapy if infection present or suspected. Use recommended “step up” approach.
Drainage and debridement endoscopically or by interventional radiology.
Manage laparoscopically or open in OR if no other option available. Refer to SAGES guidelines for safe use of laparoscopic approaches.
Pneumoperitoneum, Intestinal Ischemia, Intestinal Obstruction
Laparotomy vs. Laparoscopy as indicated
Appendicitis, Uncomplicated
IV antibiotics, transition to PO antibiotics
Appendicitis, Complicated
Abscess: IR drainage and IV antibiotics, transition to PO antibiotics
Phlegmon: IV antibiotics, transition to PO antibiotics
Perforation: IV antibiotics, transition to PO antibiotics, consider IR drainage if associated abscess
Symptomatic Cholelithiasis
Defer intervention if pain control achievable. If not, percutaneous cholecystostomy whenever possible
Acute Cholecystitis
Percutaneous cholecystostomy whenever possible, IV antibiotics, transition to PO antibiotics
Cholangitis
ERCP, IV antibiotics, consider percutaneous cholecystostomy tube vs. cholecystectomy dependent on individual patient comorbidities
Choledocholithiasis
ERCP, with sphincterotomy; deferred cholecystectomy
Diverticulitis, Uncomplicated
IV antibiotics, transition to PO antibiotics
Diverticulitis, Complicated
Abscess: IR drainage and IV antibiotics, transition to PO antibiotics
Phlegmon: IV antibiotics, transition to PO antibiotics
Comments